The prevalence of methamphetamine and other drug use during pregnancy in Hawaii

The prevalence of methamphetamine and other drug use during pregnancy in Hawaii
复制标题

DOI:
10.1177/002204260303300411
复制
发表时间:
2003-09-01
影响因子:
1.7
通讯作者:
Easa, D
Easa, D
中科院分区:
法学4区
文献类型:
--
作者:
Derauf, C;Katz, AR;Easa, D

文献摘要

被引文献

相似文献

甲基安非他明滥用在夏威夷很流行,但孕妇使用的程度尚不清楚。我们试图确定怀孕期间使用的流行率。我们对1999年11月至12月间连续出生的婴儿进行了横断面研究,确定胎粪中药物代谢物的流行率为脂肪酸乙酯:72例(17.1%);可替宁:33例(7.7%);阿片类药物:4例(0.9%); δ-9四氢大麻醛:1例(0.2%);甲基苯丙胺:3例(0.7%)。包括仅通过法医检测发现的三个阳性,怀孕期间甲基苯丙胺暴露的总体患病率为1.4%(6/443)。甲基苯丙胺的流行率低于脂肪酸乙酯的流行率(据报告,脂肪酸乙酯是接触乙醇的标志)和可替宁(一种烟草代谢物)。在夏威夷,应该更多地关注怀孕期间的酒精和烟草使用。
Methamphetamine abuse is epidemic in Hawaii, but the extent of use among pregnant women is unknown. We sought to define the prevalence of use during pregnancy. We conducted a cross-sectional study of consecutive births between November and December 1999, and determined that the prevalence of drug metabolites in meconium were fatty acid ethyl esters: 72 (17.1%); cotinine: 33 (7.7%); opiates: 4 (0.9%); delta-9 tetrahydrocannabinal: 1 (0.2%); and methamphetamine: 3 (0.7%). Including three positives discovered solely through forensic testing, the overall prevalence of methamphetamine exposure during pregnancy was 1.4% (6/443). The prevalence of methamphetamine was low compared to the prevalence of fatty acid ethyl esters, reportedly indicative of ethanol exposure, and cotinine, a tobacco metabolite. In Hawaii, more attention should be directed towards alcohol and tobacco use during pregnancy.